ADC Therapeutics (ADC Therapeutics) Days Sales Outstanding : 125.98 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is ADC Therapeutics Days Sales Outstanding?

ADC Therapeutics's average Accounts Receivable for the three months ended in Dec. 2023 was $23.18 Mil. ADC Therapeutics's Revenue for the three months ended in Dec. 2023 was $16.79 Mil. Hence, ADC Therapeutics's Days Sales Outstanding for the three months ended in Dec. 2023 was 125.98.

The historical rank and industry rank for ADC Therapeutics's Days Sales Outstanding or its related term are showing as below:

ADCT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 29.95 Med: 231.14 Max: 708.04
Current: 175.51

During the past 8 years, ADC Therapeutics's highest Days Sales Outstanding was 708.04. The lowest was 29.95. And the median was 231.14.

ADCT's Days Sales Outstanding is ranked worse than
80.88% of 889 companies
in the Biotechnology industry
Industry Median: 71.97 vs ADCT: 175.51

ADC Therapeutics's Days Sales Outstanding increased from Dec. 2022 (62.90) to Dec. 2023 (125.98).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

ADC Therapeutics Days Sales Outstanding Historical Data

The historical data trend for ADC Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ADC Therapeutics Days Sales Outstanding Chart

ADC Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

29.95

325.19

89.72

257.52

ADC Therapeutics Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															62.90	233.04	113.34	141.81	125.98

Competitive Comparison of ADC Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, ADC Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ADC Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ADC Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where ADC Therapeutics's Days Sales Outstanding falls into.

ADC Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

ADC Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (72.971	+	25.182)	/	2 )	/	69.558	*	365
=	49.0765					/	69.558	*	365
=	257.52

ADC Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (21.18	+	25.182)	/	2 )	/	16.79	*	365 / 4
=	23.181					/	16.79	*	365 / 4
=	125.98

ADC Therapeutics (NYSE:ADCT) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

ADC Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of ADC Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

ADC Therapeutics (ADC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ADC Therapeutics SA (NYSE:ADCT) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Route de la Corniche 3B, Biopole, Epalinges, CHE, 1066

Website

https://www.adctherapeutics.com

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.